Biotechnology

Deal marks entry into next-generation CAR-T cancer therapies as company expands global innovation ambitions

ICAR has developed India's first fully annotated T2T reference genome of pigeonpea, paving the way for faster breeding of climate-resilient, high-yielding varieties

Deal gives Vyome entry into the fast-growing market for next-generation autoimmune and inflammatory disease drugs

BIRAC has received nearly 200 applications under the RDI fund and shortlisted 7-8 biotech startups as demand rises for deep-tech and innovation financing

India's bioeconomy surges 18% to $195.3 billion in 2025, with BIRAC driving innovation, funding, and startup growth across the biotech ecosystem

India's technological landscape is bridging the investment gap needed to support high-innovation and long-gestation startups

Biotechnology-focused fund manager invites startup applications under Rs 1 lakh crore Research, Development and Innovation Fund

With a record wave of deal-making, IPO activity and fresh venture capital flowing into Chinese biotech in 2024-25, prices of lab monkeys used for drug testing are rising again

Biocon Biologics Chief Executive Shreehas Tambe will become CEO and managing director of the combined entity post-integration

GEAC and RCGM remain robust, science-driven regulatory bodies committed to biosafety and public interest; constructive dialogue after scientific review can effectively build trust and transparency

Indegene stock rose around 3.5 per cent to hit an intraday high of ₹568.2 on the NSE as ICICI Securities has initiated coverage with 'Add' rating

NITI Aayog suggests developing herbicide-tolerant pulses varieties and including pulses in welfare programs like PDS to boost domestic production and ensure self-sufficiency in pulses production

Shares of Anthem Biosciences surged 9 per cent to ₹820 on the BSE in Thursday's intra-day trade amid heavy volumes after reporting a strong earnings for the quarter ended June 2025.

Driven by state strategy, rapid innovation, and industrial dominance, China's surge in EVs, renewables, and biotech is not just disrupting industries, it's rewriting the global technological order

Top regulators like the US FDA and EMA are fast-tracking more Chinese drugs, granting priority review and breakthrough designations as they gain confidence in China's biotech innovation

The South Island giant moa may be Colossal Biosciences' next de-extinction project - but scientists caution the outcome won't truly be a moa

The funding will be used to build one of India's largest facilities capable of processing 150 tons of feedstock daily and also expand the scientific team and enter global markets

To commercialise transcatheter aortic valve system in India, Europe and other select markets

This initiative reinforces the company's mission to provide deep life sciences-backed, innovative shrimp and fish health and farm care solutions

The facility, which occupies approximately 524,000 square feet across two towers in HITEC City, will focus on harnessing AI, data science, and digital innovation to accelerate research and development